The Joint Laboratory for Bacterial Mediated Microcircle DNA Tumor Gene Therapy was jointly established by Shenzhen Syno Minicircle Biotechnology Co., Ltd. and Shenzhen Institutes of Advanced Technology, CAS. Both parties conduct extensive collaborative work in the research of microbial-mediated gene therapy vector construction and in vivo targeted delivery, including developing advanced technologies and new products, building a technological platform as well as cultivating talents. The Lab is dedicated to the research and development of microbial-mediated tumor gene therapy. The Lab offers a win-win situation through which Shenzhen Syno benefits from innovative technical support and SIAT gains more opportunities in industrialization and commercialization.